AI
Also, US-based Pearl has received regulatory approvals to market its AI diagnostic tool for dental radiology in Australia and New Zealand.
Clinical research is set to verify the technology's effectiveness in estimating abnormal heart movements.
The AI medical station can generate an automated diagnosis that remote care providers can access to confirm.
The tool is also able to check the lung condition of COVID-19 patients.
The AI solution automatically analyses cardiac CT scans and produces reports within 15 minutes.
This collaboration will work with an unnamed pharma company in Japan to know how its drugs behave compared to rival products.
The startup has developed an AI support tool that detects COVID-19 patterns from chest x-ray images.
The cloud-based products are designed to reduce burnout among radiologists and enhance reporting and clinical outcomes.
They are now looking to bring the algorithms to a mobile phone app to be used as a screening tool in the field.
The company develops AI tools to analyse chest x-rays and breast mammography.